129 results on '"Rothenbuchner, G."'
Search Results
2. Klinik und Therapie der thyreotoxischen Krise
3. Die endokrine Ophthalmopathie — neue pathophysiologische Gesichtspunkte durch die Bestimmung von T3, T4 und TSH nach TRH-Stimulation
4. Hautleisten und Furchen bei einer Großfamilie mit Glukose-6-Phosphatdehydrogenase-Mangel
5. Eighth annual meeting of the European Association for the Study of Diabetes: Madrid, Spain September, 6–8, 1972
6. Erhöhte Trijodthyronin (T3)-Serumspiegel bei euthyreoter Stoffwechsellage
7. TSH-Reservekapazität der Hypophyse als diagnostisches Kriterium bei Patienten mit hormonaktiven und inaktiven Tumoren der Hypophyse
8. Weitere Untersuchungen des Hautleistensystems bei Thyreoiditis lymphomatosa Hashimoto
9. Seventh Annual Meeting of the European Association for the Study of Diabetes: Southampton, England, September 15–17, 1971
10. Die Dynamik der Insulinsekretion bei der Hypothyreose vor und während der Substitutionstherapie
11. Die endokrine Ophthalmopathie — neue pathophysiologische Gesichtspunkte durch die Bestimmung von T3, T4 und TSH nach TRH-Stimulation
12. Das Verhalten des TRH-Testes bei Patienten mit hypophysärem Minderwuchs
13. TSH-Reservekapazität der Hypophyse als diagnostisches Kriterium bei Patienten mit hormonaktiven und inaktiven Tumoren der Hypophyse
14. Ophthalmoscopic Findings and Changes in Hormonal and Metabolic Parameters in “Protodiabetes”
15. List of Contributors
16. Untersuchungen mit125Jod-markiertem, synthetischem Thyrotropin-Releasing Hormone (TRH)
17. Das Verhalten des TRH-Testes bei Patienten mit hypophysärem Minderwuchs
18. Die kausale Therapie der primär-blanden Struma mit L-Thyroxin
19. The Effect of Thyrotrophin-Releasing Hormone on Serum TSH, T4, and T3 Levels in Endemic and Sporadic Nontoxic Goitre.
20. Prolactin and Thyrotropin in Thyroid Diseases: Lack of Evidence for a Physiological Role of Thyrotropin-Releasing Hormone in the Regulation of Prolactin Secretion.
21. The Effect of the β-Receptor Blockade (Propranolol) on the Endocrine and Exocrine Pancreatic Function in Man after the Administration of Intestinal Hormones (Secretin and Cholecystokinin-Pancreozymin).
22. Prolactin and thyrotropin in thyroid diseases: lack of evidence for a physiological role of thyrotropin releasing hormone in the regulation of prolactin secretion
23. HETEROGENEITY OF TSH-ACTIVITY
24. TSH DETERMINATION IN RAT SERUM BY A HOMOLOGOUS RADIOIMMUNOASSAY
25. The Influence of Hydration on T3 Elimination in Urine
26. Simultaneous Stimulation Test for the Anterior Pituitary Hormones
27. THYROXINE (T4) ASSAY IN URINE AS AN INDEX FOR THE DIAGNOSIS OF THYROID FUNCTION
28. MEASUREMENTS OF ENDOGENOUSLY LABELLED THYROXINE (T4) AND TRIIODOTHYRONINE (T3 IN SERUM AFTER ADMINISTRATION OF TRACER AMOUNTS OF RADIOIODINE IN MAN
29. Thyroid function in term newborn infants with congenital goiter
30. Effect of Acetazolamide on the Insulin Response to Intravenous Administration of Secretin
31. The Effect of Thyrotrophin-Releasing Hormone on Serum TSH, T4, and T3Levels in Endemic and Sporadic Nontoxic Goitre
32. Inhibition of TSH-stimulated radioiodine turnover and release of T4 and T3 in vivo by somatostatin
33. BLOOD LEVELS OF TSH, HGH, CORTISOL AND ACTH AFTER SYNTHETIC THYROTROPIN RELEASING FACTOR ( TRF )
34. THE DYNAMICS OF TSH-SECRETION AFTER ORAL ADMINISTRATION OF SYNTHETIC THYROTROPIN-RELEASING FACTOR (TRF) IN METABOLICALLY NORMAL SUBJECTS
35. THYROTROPIN LEVELS IN THE PLASMA OF NEWBORNS WITH CONGENITAL GOITER
36. RADIOIMMUNOLOGISCHE BESTIMMUNG VON GASTRIN IM MENSCHLICHEN SERUM
37. THYROTROPHIN (TSH), HUMAN GROWTH HORMON (HGH) IN HYPOTHYROID PATIENTS AND PATIENTS WITH ENDOCRINE OPHTHALMOPATHY AFTER TRF INJECTION
38. INSULIN DEPENDENT DIABETES MELLITUS AND HGH, TSH IN SERUM FOLLOWING THYROTROPHIN RELEASING FACTOR (TRF)
39. THE INFLUENCE OF TOTAL STARVATION ON THE PITUITARY-THYROID-AXIS IN OBESE INDIVIDUALS
40. THE ALTERATIONS OF TOTAL-THYROXINE AND TOTAL-TRIIODOTHYRONINE AFTER ORAL APPLICATION OF SYNTHETIC THYROTROPIN-RELEASING FACTOR (TRF) IN METABOLICALLY NORMAL SUBJECTS
41. MODIFICATION OF BASAL AND ARGININE-INDUCED GROWTH HORMONE SECRETION BY CONCOMITANT FAT ADMINISTRATION
42. Untersuchungen mit125Jod-markiertem, synthetischem Thyrotropin-Releasing Hormone (TRH)
43. Inhibition of TSH-stimulated radioiodine turnover and release of T 4 and T 3 in vivo by somatostatin
44. MEASUREMENTS OF ENDOGENOUSLY LABELLED THYROXINE (T4) AND TRIIODOTHYRONINE (T3IN SERUM AFTER ADMINISTRATION OF TRACER AMOUNTS OF RADIOIODINE IN MAN
45. [Treatment of hyperthyroidism during agranulocytosis induced by thyrostatics].
46. [Increased triiodothyronine (T3) serum level in euthyroid metabolic conditions].
47. [Preclinical hypothyroidism].
48. [Aetiological treatment of benign goitre with l-thyroxine (author's transl)].
49. [TSH reserve capacity of hypophysis as diagnostic criterion in patients with hormone-active and inactive pituitary tumors].
50. [Clinical aspects and therapy of thyreotoxic crisis].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.